Pivot Europe Pharmaceuticals

BetterLife Europe Pharmaceuticals was a European subsidiary/vehicle associated with BetterLife Pharma that was formed to commercialize cannabinoid-based and wellness products in Europe. Contemporary company disclosures described the entity under the name Pivot Europe Pharmaceuticals AG, with operations tied to Liechtenstein and Switzerland and built around Solmic AG's micelle formulation technology to improve oral bioavailability of cannabidiol and other poorly water-soluble compounds. The business appears to have focused on commercial products rather than a conventional clinical-stage therapeutic pipeline. Later disclosures indicate the entity was renamed BetterLife Europe Pharmaceuticals AG and was subsequently sold, along with Solmic-related assets, in late 2021. As a result, the requested name corresponds to a real health-related company entity, but not to its later most commonly referenced operating name.